What Is Driving The Biophytis (BPTS) Stock Higher In Pre-Market Trades?
Following the release of the findings of clinical research, Biophytis S.A. (NASD: BPTS) is climbing the charts today, rising 24.36% to trade at $0.7337 at the most recent check in premarket activity. What research findings have BPTS made public? The complete findings of Biophytis’ phase 2-3 COVA clinical research assessing Sarconeos (BIO101) for the management […]